Nasdaq-Listed Company Plans $1 Billion Bitcoin Purchase to Fuel Expansion
Basel Medical Group (BMGL), a Nasdaq-listed healthcare company, is in exclusive talks to acquire $1 billion worth of Bitcoin ($BTC ) through a stock swap deal with institutional investors and high-net-worth individuals. The transaction is expected to close this quarter.
### **Key Highlights of the Deal:**
- **Strategic Move:** BMGL aims to strengthen its balance sheet and diversify its treasury holdings while expanding in Asia’s fast-growing healthcare market.
- **Growth in Asia:** The company believes this financial shift will enhance its ability to pursue mergers, acquisitions, and other strategic opportunities in the region.
- **Resilient Asset Base:** By adding Bitcoin to its reserves, BMGL seeks to build a more stable and diversified financial structure resistant to market volatility.
Dr. Darren Chhoa, CEO of Basel Medical Group, stated that this $1 billion Bitcoin investment will provide the company with one of the strongest balance sheets among Asian healthcare providers, boosting its flexibility in deal-making and positioning it as a leading medical group in emerging Asian markets.
This move highlights the growing trend of corporations turning to Bitcoin as a treasury asset to support long-term growth strategies.